Kuros Biosciences Ltd. (CSBTF)

27.85 -0.55 (-1.94%) USD  |  OTCM  |  Mar 27, 09:30
More

Kuros Biosciences Total Expenses (Quarterly)

Total Expenses (Quarterly) Chart

View Total Expenses (Quarterly) for CSBTF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (Quarterly) Range, Past 5 Years

View Total Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Quarterly) Benchmarks

View Total Expenses (Quarterly) Benchmarks
Start Trial
EvoNext Holdings SA --
Basilea Pharmaceutica AG --
Santhera Pharmaceuticals Holding AG --
BeOne Medicines Ltd. Upgrade
AC Immune SA Upgrade

Total Expenses (Quarterly) Related Metrics

Enterprise Value Upgrade
Earnings Yield Upgrade
Operating Earnings Yield Upgrade
Normalized Earnings Yield Upgrade